Status:
COMPLETED
Prevalence and Characteristics of Fabry Disease (FD) in Patients With Stroke or Small Fiber Neuropathy
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Shire International GmbH
Conditions:
Fabry Disease
Eligibility:
All Genders
18-60 years
Brief Summary
FD is pan-ethnic. Its reported annual incidence of 1 in 100,000 may underestimate the true prevalence of the disease. Indeed, recently, in addition with affected males FD developing a "classic" phenot...
Detailed Description
FD is pan-ethnic. Its reported annual incidence of 1 in 100,000 may underestimate the true prevalence of the disease. Indeed, recently, in addition with affected males FD developing a "classic" phenot...
Eligibility Criteria
Inclusion
- patient over 18 yo and under 60 yo
- diagnosed with a TIA / stroke (ischemic and haemorrhagic strokes) based on clinical evaluation and MRI
- diagnosed with small fibers neuropathy (SFN) with normal nerve conduction studies in conventional electrophysiology
Exclusion
- patients over 60 yo
Key Trial Info
Start Date :
March 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 24 2021
Estimated Enrollment :
379 Patients enrolled
Trial Details
Trial ID
NCT03230149
Start Date
March 12 2018
End Date
December 24 2021
Last Update
September 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bicêtre, UNSIV (neurovascular stroke unit)
Le Kremlin-Bicêtre, France, 94270